A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals.

ABSTRACT:

Introduction

The under-reporting of adverse drug events (ADEs) is an international health concern. A number of studies have assessed the root causes but, to our knowledge, little information exists relating under-reporting to practices and systems used for the recording and tracking of drug-related adverse event observations in ambulatory settings, institutional settings, and retail pharmacies.

Objectives

Our objective was to explore the process for reporting ADEs in US hospitals, ambulatory settings, and retail pharmacies; to explore gaps and inconsistencies in the reporting process; and to identify the causes of under-reporting ADEs in these settings.

Methods

The Tufts Center for the Study of Drug Development (Tufts CSDD) interviewed 11 thought leaders and conducted

SUBMITTER: Stergiopoulos S 

PROVIDER: S-EPMC5045838 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature